Augmenter of liver regeneration gene expression in human colon cancer cell lines and clinical tissue samples

Journal of B.U.ON.

Volumn 20, Issue 1, 2015, Pages 84-91

  Gatzidou, Elisavet ^a   Mantzourani, Marina ^b   Giaginis, Constantinos ^a,c   Giagini, Athina ^a   Patsouris, Efstratios ^a   Kouraklis, Gregory ^a   Theocharis, Stamatios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF THE AEGEAN   (Greece)

Author keywords

Augmenter of liver regeneration; Colon cancer cell lines; Colorectal carcinoma; Quantitative real time PCR

Indexed keywords

AUGMENTER OF LIVER REGENERATION PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; RNA; SCATTER FACTOR; UNCLASSIFIED DRUG; AUGMENTER OF LIVER REGENERATION FACTOR; PROTEIN;

ARTICLE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CANCER CELL LINE; COLORECTAL TUMOR; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIMARY TUMOR; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; AGED; CANCER GRADING; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; LIVER REGENERATION; METABOLISM; MIDDLE AGED; PATHOLOGY; UPREGULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; LIVER REGENERATION; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 84928703957     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Key TJ, Schatzkin A, Willett WC et al. Diet, nutrition and the prevention of cancer. Public Health Nutr 2004;7:187-200.
4. Cunningham D, Atkin W, Lenz HJ et al. Colorectal cancer. Lancet 2010;375; 1030-1047.
5. LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (HSS) from rat liver. J Physiol 1975;248:273-284.
6. Fleig WE, Hoss G. Partial purification of rat hepatic stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes. Hepatology 1989;9:240-248.
7. Margeli AP, Skaltsas SD, Spiliopoulou CA, Mykoniatis MG, Theocharis SE. Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats. Liver 1999;19:519-525.
8. Liatsos GD, Mykoniatis MG, Margeli A, Liakos AA, Theocharis SE. Effect of acute ethanol exposure on hepatic stimulator substance (HSS) levels during liver regeneration: protective function of HSS. Dig Dis Sci 2003;48:1929-1938.
9. Zhou Z, Tan R, Su S, Zhou C. Effects of human HSS on hepatocyte and hepatoma cell proliferation and D-GAL induced acute liver failure. Chin Med Sci J 1992;7:197-200.
10. Francavilla A, DiLeo A, Polimeno L et al. The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50, 000 and 300, 000 sub- fractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology 1986;6:1346-1351.
11. Francavilla A, Hagiya M, Porter KA, Polimeno L, Ihara I, Starzl TE. Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology 1994;20:747-757.
12. Francavilla A, Ove P, Polimeno L et al. Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res 1987;47:5600-5605.
13. Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994;19:489-497.
14. Terblanche J, Porter KA, Starzl TE, Moore J, Patzelt L, Hayashida N. Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet 1980;151:538-544.
15. Starzl TE, Porter KA, Putnam CW. Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet 1975;2:1241-1242.
16. Starzl TE, Jones AF, Terblanche J, Usui S, Porter KA, Mazzoni G. Growth-stimulating factor in regenerating canine liver. Lancet 1979;1:127-130.
17. Di-Fonzo A, Ronchi D, Lodi T et al. The mitochondrial disulfide relay system protein GFER is mutated in au- tosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am J Hum Genet 2009;84:594-604.
18. Gatzidou E, Kouraklis G, Theocharis S. Insights on augmenter of liver regeneration cloning and function. World J Gastroenterol 2006;12:4951-4958.
19. Hagiya M, Francavilla A, Polimeno L et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci USA 1994;91:8142-8146.
20. Giorda R, Hagiya M, Seki T et al. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996;2:97-108.
21. Cheng J, Zhong YW, Liu Y et al. Cloning and sequence analysis of human genomic DNA of augmenter of liver regeneration. World J Gastroenterol 2000;6:275-277.
22. Lisowsky T, Weinstat-Saslow DL, Barton N, Reeders ST, Schneider MC. A new human gene located in the PKD1 region of chromosome 16 is a functional homo- logue to ERV1 of yeast. Genomics 1995;29:690-697.
23. Li Y, Wei K, Lu C et al. Identification of hepatopoi- etin dimerization, its interacting regions and alternative splicing of its transcription. Eur J Biochem 2002;269:3888-3893.
24. Wu CK, Dailey TA, Dailey HA, Wang BC, Rose JP. The crystal structure of augmenter of liver regeneration: A mammalian FAD-dependent sulfhydryl oxidase. Protein Sci 2003;12:1109-1118.
25. Lisowsky T. Dual function of a new nuclear gene for oxidative phosphorylation and vegetative growth in yeast. Mol Gen Genet 1992;232:58-64.
26. Yanez RJ, Rodriguez JM, Nogal M et al. Analysis of the complete nucleotide sequence of African swine fever virus. Virology 1995;208:249-278.
27. Coppock DL, Cina-Poppe D, Gilleran S. The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1. Genomics 1998;54:460-468.
28. Stein G, Lisowsky T. Functional comparison of the yeast scERVl and scERV2 genes. Yeast 1998;14:171-180.
29. Senkevich TG, White CL, Koonin EV, Moss B. A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation. Proc Natl Acad Sci USA 2000;97:12068-12073.
30. Levitan A, Danon A, Lisowsky T. Unique features of plant mitochondrial sulfhydryl oxidase. J Biol Chem 2004;279:20002-20008.
31. Polimeno L, Lisowsky T, Francavilla A. From yeast to man - from mitochondria to liver regeneration: a new essential gene family. Ital J Gastroenterol Hepatol 1999;31:494-500.
32. Lee J, Hofhaus G, Lisowsky T. Ervlp from Saccharo- myces cerevisiae is a FAD-linked sulfhydryl oxidase. FEBS Lett 2000;477:62-66.
33. Lisowsky T, Lee JE, Polimeno L, Francavilla A, Hofhaus G. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis 2001;33:173-180.
34. Green FL, Page DL, Fleming ID et al. Cancer Staging Manual (6th Edn). New York: Springer Verlag, 2002.
35. Sobin LH, Wittekind C (Eds). TNM Classification of Malignant Tumors (6th Edn). New York: Wiley, 2002.
36. Martiat P, Maisin D, Philippe M et al. Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers. Br J Haematol 1990;75:355-358.
37. Martiat P, Maisin D, Philippe M et al. Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers: a correction. Br J Haematol 1990;76:158.
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 2001;25:402-408.
39. Dayoub R, Wagner H, Bataille F et al. Liver regener-ation associated protein (ALR) exhibits antimetastat- ic potential in hepatocellular carcinoma. Mol Med 2011;17:221-228.
40. Thasler WE, Schlott T, Thelen P et al. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 2005;47:57-66.
41. Yu HY, Xiang DR, Huang HJ, Li J, Sheng JF. Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2010;9:492-498.
42. Lange H, Lisowsky T, Gerber J et al. An essential func-tion of the mitochondrial sulfhydryl oxidase Ervpl/ALR in the maturation of cytosolic Fe/S proteins. EMBO Rep 2001;2:715-720.
43. Daithankar VN, Farrell SR, Thorpe C. Augmenter of liver regeneration: substrate specificity of a flavin-de- pendent oxidoreductase from the mitochondrial inter- membrane space. Biochemistry 2009;48:4828-4837.
44. Pawlowski R, Jura J. ALR and liver regeneration. Mol Cell Biochem 2006;288:159-169.
45. Comoglio PM, Boccaccio C. Scatter factors and invasive growth. Semin Cancer Biol 2001;11:153-165.
46. Ilowski M, Kleespies A, de-Toni EN et al. Augmenter of liver regeneration (ALR) protects human hepato- cytes against apoptosis. Biochem Biophys Res Commun 2011;404:148-152.
47. Polimeno L, Pesetti B, Lisowsky T et al. Protective ef-fect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neu-roblastoma cells. Free Radic Res 2009;43:865-875.
48. Polimeno L, Pesetti B, De-Santis F et al. Decreased expression of the augmenter of liver regeneration results in increased apoptosis and oxidative damage in human-derived glioma cells. Cell Death Dis 2012;3:e289.
49. Wang N, Sun H, Shen Y et al. Augmenter of liver re-generation inhibits apoptosis of activated human peripheral blood lymphocytes in vitro. Immunopharma- col Immunotoxicol 2013;35:257-263.